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Abstract 
Peripheral inflammation, both during the prenatal period and in adulthood, impairs adult 
neurogenesis. We hypothesized that, similar to other programming effects of prenatal 
treatments, only prenatal inflammation causes long-term consequences in adult 
neurogenesis and its neurogenic niche. To test this, pregnant Wistar rats were 
subcutaneously injected with lipopolysaccharide (LPS; 0.5mg/kg) or saline solution 
every other day from gestational/embryonic day (GD) 14 to 20. In addition adult animals 
were injected with a single intraperitoneal saline or LPS injection (1mg/kg) and the 
effects on neurogenesis were assessed 7 days later. Alternatively, to evaluate long-term 
consequences of adult LPS injections, LPS (1mg/kg) was administered peripherally to 
adult rats 4 times every other day, and the effects on neurogenesis were assessed 60 
days later.  
Prenatal and adult LPS treatments reduced adult neurogenesis and provoked specific 
microglial (but not astroglial) activation in the dentate gyrus (DG). However, only 
prenatal inflammation-mediated effects were long-lasting (at least 60 days). Moreover, 
these effects were specific to the DG since the Subventricular Zone (SVZ) and the 
Rostral Migratory Stream (RMS) were not affected. In addition, these stimuli caused 
differential effects on the molecular components of the neurogenic niche; only prenatal 
LPS treatment reduced the local levels of TGF-β1 mRNA in the DG. Finally, TGF-β1 
exerted its pro-neurogenic effects via the Smad2/3 pathway in a neural stem cell 
culture.  
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Taken together, these data add evidence to the duration, regional specificity and 
dramatic consequences of prenatal immune programming on CNS physiology, 
compared with the limited response observed in the adult brain. 
Keywords: prenatal programming, inflammation, adult neurogenesis, microglial 
activation, neurogenic niche, TGF-β1. 
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Research highlights 
Prenatal, but not adult inflammation, elicits long-term reduction on adult 
neurogenesis in the hippocampus (but not the SVZ or the RMS) via TGF-1  
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INTRODUCTION 
Neurogenesis from adult neural stem/progenitor cells (NSC) occurs in the subgranular 
zone (SGZ) of the dentate gyrus (DG) and in the subventricular zone of the lateral 
ventricle (SVZ). Several studies have shown that pro- and anti-inflammatory stimuli 
occurring in the CNS or in the periphery modulate adult neurogenesis (Ekdahl et al, 
2003, Graciarena et al, 2010, Mathieu et al, 2010b, Monje et al, 2003, Ormerod et al, 
2012, reviewed in Mathieu et al, 2010a). 
NSCs reside within an environment or niche which modulates NSC proliferation and 
differentiation. The cellular and molecular factors that modulate these effects need to be 
further characterized. Microglial cells are components of this niche and are capable of 
altering adult neurogenesis via net changes in the pattern of secreted factors, including 
immune cytokines (Ekdahl et al, 2009, Mathieu et al, 2010a, Mathieu et al, 2010b, Perry 
et al, 2002, Simard & Rivest, 2004, Whitney et al, 2009, Ziv et al, 2006). Cytokines are 
part of the molecular components of the neurogenic niche in normal conditions and 
have shown to play a central role in processes affecting NSCs biology (Gage, 2000, 
Mathieu et al, 2010a, Perry et al, 2002). Among them, pro-inflammatory Interleukin (IL)-
6 has shown to exert anti-neurogenic effects in the adult DG (Monje et al, 2003, 
Vallieres et al, 2002). Conversely, the anti-inflammatory cytokine Transforming Growth 
Factor beta-1 (TGF-β1) has proven to be pro-neurogenic in vitro and in vivo (Battista et 
al, 2006, Graciarena et al, 2010, Mathieu et al, 2010a, Mathieu et al, 2010b). 
Nevertheless, the role of local cytokine expression on adult neurogenesis, the regional 
and temporal specificity of these effects, as well as the intracellular pathways involved 
in this modulation awaits further characterization. 
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Despite the particular regions that retain neurogenic potential, the adult CNS is mainly 
characterized by its limited plasticity. On the contrary, the developing CNS is 
characterized by a series of temporal windows where key proliferation, differentiation 
and migration events occur, which will in turn determine many of the CNS functions in 
the adult. These critical developmental steps are prone to be altered as a consequence 
of external influences (de Graaf-Peters & Hadders-Algra, 2006) which can be reflected 
on diverse spectra of CNS dysfunctions in the adult. The concept of programming has 
been built considering the long term effects that these early external influences have on 
the physiology and behavior of adult individuals. Programming includes alterations in 
adult neuronal CNS functions or immune responses caused by early (pre- or early 
postnatal) administration of inflammatory stimuli. In this regard, experimental studies 
have shown that inflammation during the prenatal period can lead to diverse alterations 
in CNS functions in the adult, including behavioral and cognitive impairments (Bilbo & 
Schwarz, 2009), alterations of the Hypothalamic-Pituitary-Adrenal axis activity (Reul et 
al, 1994), white matter damage and even cerebral palsy (Shi et al, 2003). In particular, 
we and others have shown that adult neurogenesis in the DG is impaired by prenatal 
inflammation triggered by lipopolysaccharide (LPS), a bacterial endotoxin (Graciarena 
et al, 2010); or polyriboinosinic-polyribocytidylic acid (PolyI:C), a synthetic analog of 
double-stranded RNA that mimicks components of a viral infection (Meyer et al, 2006). 
In particular, prenatal LPS administration may model bacterial vaginosis, a condition 
during pregnancy that put the developing fetus into contact with LPS (Dammann & 
Leviton, 1997, Purwar et al, 2001, Romero et al, 1989, Thorsen et al, 1998). 
Approximately 14% of pregnant women get bacterial vaginosis, which leads to a pro-
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inflammatory environment and has been shown to lead to white matter damage, 
cognitive limitations and even cerebral palsy (Dammann & Leviton, 1997, Yoon et al, 
1997). In addition, epidemiological studies have linked infections during pregnancy to 
later development of neuropsychiatric disorders in the offspring (Hultman et al, 1999, 
Mednick et al, 1988). These observations increase the relevance of possible prenatal 
LPS effects on the human population.   
Since inflammation can impair adult neurogenesis both at the prenatal period and in the 
adulthood, here we aimed to compare the duration and magnitude of this effect when 
LPS is administered prenatally or in adult animals. Also we studied whether both adult 
neurogenic regions (DG and SVZ) are affected by LPS treatment. Finally, we explored 
the cellular and molecular alterations in the neurogenic niche that could explain the 
different effects of adult vs pre-natal LPS. 
 
METHODS 
Animals 
Adult Wistar rats (250-300 g) were bred in the animal house at the Leloir Institute. 
Animals were housed under controlled temperature (22 ± 2°C) and artificial light under a 
12-h cycle, with water and food available ad libitum. All dams were naive breeders. All 
animal procedures were performed according to the rules and standards for the use of 
laboratory animals of the National Institutes of Health, USA. Animal experiments were 
approved by the Ethical Committee of the Leloir Institute Foundation. 
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LPS treatment and BrdU staining 
Prenatal LPS treatment 
Pregnant dams were housed individually. Each received a subcutaneous (sc) injection 
of LPS (0.5 mg/kg; strain 0111:B4, Sigma–Aldrich, MA, USA) or saline on 
gestational/embryonic days (GD) 14, 16, 18, and 20. The litters were culled to 10 pups, 
weaned at postnatal day (PD) 21, and housed with no more than 5 animals per cage 
until adulthood (PD60). One to two pups from each litter were randomly sampled and 
assigned to an experimental group to reduce the influence of litter effects on the 
variables measured, as it has been previously suggested (Zorrilla, 1997). The time of 
appearance of typical developmental parameters such as eye opening, ear detachment 
and testis descent was unaffected by prenatal LPS administration, as it was the weight 
of the pups between birth and weaning. In depth characterization of the prenatal LPS 
model in terms of maternal behavior and other parameters can be found in (Graciarena 
et al, 2010). 
Adult LPS treatment and BrdU injections 
Adult male rats prenatally treated with saline received a single intraperitoneal (ip) 
injection of either LPS (1 mg/kg; Saline/LPS7 group) or saline (Saline/Saline7 group). 
Adult male rats prenatally treated with LPS received a single ip injection of saline to 
control for the effect of injection (LPS/Saline7 group). The adult injection was followed 
immediately by 7 daily ip injections of 50 mg/kg 5-bromo-20-deoxiuridine (BrdU, Sigma–
Aldrich) and perfusion at the 7th day (Figure 1a) for immunohistochemistry studies as 
described below. For RNA isolation animals were decapitated on the 7th day.  
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To study the DG, a total number of 16 animals (Saline/Saline7, n=6; Saline/LPS7, n=4; 
LPS/Saline7, n=6) were processed for immunostaining procedures and 21 animals 
(Saline/Saline7, n=7; Saline/LPS7, n=6; LPS/Saline7, n=8) for mRNA quantitation 
protocols. For the SVZ and RMS, a total number of 9 animals (n=3/group) were 
processed for immunostaining procedures.  
Alternatively, adult male rats with no prenatal treatment received 4 ip injections of LPS 
(1 mg/kg, LPS60 group) or saline (Saline60 group) every other day. After 60 days, rats 
received 7 daily ip injections of BrdU (50 mg/kg), were perfused or decapitated at the 
7th day (Figure 2a). A total number of 16 animals (8 for immunohistochemistry and 8 for 
RNA isolation, 4 in each group) were processed for this experimental protocol. 
Tissue sections 
Animals were deeply anesthetized and transcardially perfused with heparinized saline 
followed by cold 4% paraformaldehyde in 0.1 M phosphate buffer (PB; pH=7.2). Brains 
were placed in the same fixative overnight at 4°C, cryoprotected in 30% sucrose in PB 
0.1 M, frozen in isopentane. Serial coronal sections throughout the hippocampus and 
serial sagittal sections throughout the SVZ and RMS were cut in a cryostat. The 40 µm 
sections were used for free floating immunostaining. 
Immunostaining 
Co-localization of BrdU with other markers was performed as previously described 
(Graciarena et al, 2010). Briefly, every sixth coronal section was incubated for 2 hrs in 
50 % formamide at 65 °C, washed once in 2x saline-sodium citrate (SSC; 0.3 M NaCl, 
0.03 M sodium citrate), incubated for 30 min at 37°C in 2 M HCl, rinsed in 0.1 M borate 
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buffer pH 8.5, and thoroughly washed in Tris-buffered saline (TBS; Tris-HCl 50 mM pH 
7.4, NaCl 150 mM). Sections were then blocked in 0.1 % Triton X-100, 1% donkey 
serum in TBS (blocking solution) for 45 min at room temperature. Primary antibodies 
were diluted in blocking solution and sections were incubated for 48 hrs at 4°C. After 2 
washes with 0.1 M PB, sections were incubated in secondary antibodies diluted in 0.1 M 
PB for 2 hrs at room temperature. Sections were then washed with 0.1 M PB and 
mounted in Mowiol (Calbiochem, La Jolla, CA, USA). 
Primary antibodies used were rat anti-BrdU (1:200; Abcam, Cambridge, UK); mouse 
anti-polysialic acid neuronal cell adhesion molecule (PSA-NCAM, 1:200, kindly provided 
by Dr. Seki, Department of Anatomy, Juntendo University School of Medicine, Tokyo, 
Japan); mouse anti-NeuN (1:200, Chemicon); rabbit anti-doublecortin (Dcx, 1:400, 
Abcam); Griffonia simplicifolia lectin (GSAI-B4, 1:200, Vector) and rabbit anti-glial 
fibrillary acidic protein (GFAP, 1:500; Chemicon, Temecula, CA). 
Secondary antibodies used were Cy2-conjugated donkey anti-rat, Cy3-conjugated 
donkey anti-mouse, Cy3-conjugated donkey anti-rabbit and Cy2-streptavidin (1:200; 
Jackson Laboratories, West Grove, PA).  
For staining with Dcx, GSAI-B4 or GFAP alone, every sixth coronal section were 
incubated in the primary antibody diluted in blocking solution for 24 hrs at 4°C. After 2 
washes with 0.1 M PB, sections were incubated with secondary antibodies diluted in 0.1 
M PB for 2 hrs at RT. Sections were then washed with 0.1 M PB and mounted in Mowiol 
(Calbiochem). 
Quantitation of neurogenesis and microglial activation 
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Neuronal differentiation.  One-in-six series of coronal or sagittal sections (40 μm-thick) 
from the entire Hippocampus or SVZ were observed at 40x magnification in a Zeiss 
LSM 510 laser scanning confocal microscope equipped with an argon and He/Ne laser 
that emitted at 488 nm and 543 nm, respectively. Four fields were randomly selected for 
each rat and scanned along the entire z-axis. Between 50 and 100 total BrdU positive 
cells have been counted in each rat for the hippocampus and between 50 and 400 total 
BrdU positive cells for the SVZ. 
Neurons born in the adult brain were identified as cells labeled with BrdU and a 
neuronal marker, such as PSA-NCAM or Dcx (young neurons), or NeuN (mature 
neurons). Neurogenesis was expressed as the percentage of double-labeled cells over 
the total BrdU-positive cell population. Sections were counted using a double-blind 
procedure. 
Total newborn neurons.  For the DG, one-in-six series of coronal sections (40 μm-thick) 
spanning the entire hippocampus (-2.3 mm to –5.2 mm from bregma) were stained for 
Dcx by immunofluorescence. Dcx-labeled cells in the SGZ were quantified at 40X 
magnification under a fluorescence microscope. The total number of positive cells 
through the entire GCL was estimated and then divided by the volume of the DG. For 
the calculation of the volume, one-in-six sections were photographed using a Nikon 
Eclipse E600 microscope and a CX900 camera (MicrobrightField Inc., USA) with a 10x 
magnification, and Image J software (Media Cybernetics, Silver Spring, MD) was used 
to delineate the GCL area. The volume was estimated by multiplying each section area 
by the section’s width (0.04 mm) and the total number of sections obtained for the whole 
DG. 
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For the SVZ and RMS, one-in-six series of sagittal sections (40 μm-thick) were stained 
for BrdU and Dcx immunofluorescence. The percentage of double-labeled cells over the 
total BrdU-positive cell population was quantified at 40X magnification. The total number 
of BrdU-positive cells through the entire SVZ and RMS was divided by the volume of the 
SVZ or the RMS. The volume was calculated using the LSM Image Browser. The 
analyzed area was defined manually and the numeric area value given by the program 
was multiplied by the thickness of the z-stack analysis.  
Microglial activation. GSAI-B4 was used to assess microglial activation based on 
positive staining and cell morphology (Kreutzberg, 1996). Four stages (I to IV) of 
microglial activation were defined as already described (Mathieu et al, 2010a). At stage 
I, cells have rod-shaped cell bodies with fine, ramified processes and are defined as 
resting microglial cells. At stage II, cells have elongated cell bodies with long thick 
processes; at stage III cells had small, thick processes and a rounded morphology. At 
stage IV cells have a rounded morphology with no processes and vacuolated 
cytoplasm, and stain for EDI, a marker of phagocytic activity. Stages II, III and IV are 
defined as activated microglial cells. Stages II and III were counted throughout all the 
DG in one-in-six coronal sections of the hippocampus. Total activated cells per mm3 of 
DG were calculated by extrapolating cell number to the volume of the DG.  
RNA isolation, reverse transcription and real time PCR (RT-PCR) 
Adult animals were decapitated, their brains were quickly removed and the whole 
hippocampus dissected. Tissue was snap-frozen in liquid nitrogen and stored at -80 °C. 
RNA isolation, reverse transcription and real time PCR were performed as described 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
12 
 
elsewhere (Battista et al, 2006). Briefly, the tissue was homogenized in TRI Reagent 
(Sigma) and then extracted with chloroform. The aqueous phase was precipitated with 
isopropanol, washed with ethanol and suspended in 20 μl of RNAse-free milliQ water. 
Reverse transcription was performed by incubating 10 μg of the RNA with oligo-dT 
(Invitrogen, San Diego, CA, USA) and SuperScript First-strand Synthesis System 
(Invitrogen), according to manufacturer’s protocol. For quantitative RT-PCR reaction, 24 
μl of SYBR Green Master Mix was added to 1 μl of cDNA. The specificity of PCR 
primers was tested, and a single DNA band of the expected molecular size was 
observed in a 1.5 % agarose gel electrophoresis stained with ethidium bromide. In 
addition, a single peak in the iCycler plot was observed after a melting curve was 
performed. Each sample was tested in triplicate. To compare mRNA expression among 
treatments, the amount of mRNA was expressed as the ratio between TGF-β1 or IL-6 
and β2-microglobulin levels.  
NSC culture and immunocytochemistry 
Adult hippocampal NSC culture was prepared as described elsewhere (Battista et al, 
2006). Cells were maintained in DMEM/F12 medium supplemented with FGF-2 
(Peprotech, DF, Mexico) and N2 1X (Invitrogen), in dishes previously coated with poly-
L-ornithine and laminin (Sigma).  
For differentiation experiments: 3.5 104 cells⁄ ml were plated on poly-L-ornithine⁄ laminin-
coated cover slides. One day after plating, cells were transduced with equivalent doses 
of adenovectors recombinant for Smad7 or β-galactosidase (5x108 infective 
particles/ml) in DMEM/F12 alone. After 2 hs the medium was replaced by DMEM/F12 
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with N2, and a low FGF concentration (0.5 ng ⁄ml).  The next day, cells were incubated 
with the same medium with or without TGF-β1 (Peprotech) at a concentration 1 ng/ml. 
The medium with or without TGF-β1 was replaced every 48 hrs and on the fifth day after 
adenovector transduction, cells were fixed in 4% paraformaldehyde for 10 min at 4°C.  
For β-III-tubulin (Tuj I) immunofluorescence, fixed cells were blocked for 30 min in 1% 
donkey serum in PBS with 0.1% Triton X-100, and then incubated in mouse anti-Tuj I, 
1:1000 (Promega Corporation, Madison, USA) for 2 h at RT. Cells were then washed 
three times with PBS and incubated in Cy3-conjugated donkey anti-mouse, 1:1000 
(Jackson) for 2 h at RT. Cells were then washed three times with PBS and cell nuclei 
were stained with Hoescht 1:1000 (Sigma) in PBS for 5 min, followed by three washes 
with PBS. Cells were finally mounted in Mowiol (Calbiochem).  
The coverslides were observed in a fluorescence microscope, and four random areas 
were photographed within each coverslide. Each treatment was performed in three 
coverslides. Within each area, total nuclei (positive for Hoescht) and cells of a neuronal 
phenotype (positive for β-III-tubulin) were counted. Then, for each coverslide, the 
percentage of positively stained cells over the total number of cells was calculated. Cell 
counting were performed using the Image Pro Plus software, in a double blind 
procedure. 
Western blot 
Protein extracts were obtained from NSC lysates at 24 hs after adenovector 
transduction, and 30 min after addition of TGF-β1 to the medium at concentrations of 
0.1 or 1ng/ml. Briefly, cells were disaggregated, centrifuged and suspended in sample 
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buffer (62.5 mM pH 6.8 Tris-HCl, 2% SDS, 10% glycerol, 0.01% 50mM DTT in MilliQ 
water) with addition of protease inhibitors (GE Healthcare, USA) on ice. The samples 
were then briefly sonicated (5 sec). Bradford protein assays were performed to 
determine total protein concentration in each sample. 30 μg of protein samples were 
separated in a 12% SDS-polyacrylamide gel and transferred onto Nitrocellulose 
membranes using a Trans-blot apparatus (BioRad, Hercules, CA).  Membranes were 
blocked with 5% w/v skim milk in PBS with 0.05% v/v Tween 20 for 1 h, and incubated 
in appropriate dilutions of primary antibodies (rabbit anti-rat Smad7 1:500 and rabbit 
anti-rat p-Smad2/3 1:500, both purchased at Cell signaling; mouse anti-rat actin 1:1000, 
purchased at Sigma) overnight at 4°C. After extensive washing, membranes were 
incubated with peroxidase-conjugated secondary antibodies (HRP Goat anti-rabbit 
1:2000, HRP Goat anti-mouse 1:2000, Jackson) for 2 hrs, and washed before detection 
with ECL chemoluminescence (GE). Optical Density (OD) of p-Smad2/3 and actin 
bands was measured using Image J software (Rasband WS. Image J. Bethesda, 
Maryland, USA: US National Institutes of Health). Values were normalized according to 
total protein loading and expressed as percentage of the density corresponding to the 
control group. OD quantitations show an average of three independent experiments. 
Adenoviral vector preparation 
Adenovectors expressing β-galactosidase and Smad7 were generated, controlled, and 
used as previously described (Ferrari et al, 2004). Stocks were quantified by plaque 
assay (final titers: Adβgal = 5.56 × 1011 pfu/μL, AdSmad7 = 1.05 × 1012 pfu/μL), and had 
less than 1 ng/mL of endotoxin (E-TOXATE Reagents, Sigma). Viral stocks were free of 
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autoreplicative particles. AdSmad7 was kindly provided by M. Fujii (Department of 
Biochemistry, The Cancer Institute, Tokyo, Japan). 
Statistical Analysis 
Data is presented as the mean ± standard error of the mean (SEM). Comparisons were 
performed using Student’s t-test (two-tailed), One- and Two-way analysis of variance 
(ANOVA) followed by Tukey´s post-hoc test. Differences were considered significant 
when p<0.05. Data were previously checked to fulfill normality and homocedacy criteria.
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RESULTS 
Prenatal and adult LPS treatments reduce adult neurogenesis in the DG to the 
same extent, but only prenatal LPS effects are long-lasting. 
We first sought to compare the effects of the prenatal and adult LPS treatment on adult 
neurogenesis. Pregnant rats were treated with 0.5 mg/kg LPS or saline during GD 14, 
16, 18 and 20 (Figure 1A). The adult offspring of dams treated with saline received one 
i.p. injection of saline solution (Saline/Saline7 group) or LPS (1mg/kg, Saline/LPS7 
group) at postnatal day (PD) 60, whereas the adult offspring prenatally treated with LPS 
received saline at PD 60 (LPS/Saline7 group). This experimental design allowed us to 
control for changes in adult neurogenesis elicited by handling and injection of the 
animals. The adult treatment was immediately followed by 7 daily i.p. BrdU injections 
from PD60 to PD66, and the animals were sacrificed and perfused at PD67 for posterior 
immunostaining analyses (Figure 1A). Both LPS/Saline7 and Saline/LPS7 groups 
showed a reduced neuronal differentiation rate, identified as cells stained for both BrdU 
and PSA-NCAM (Figure 1B, One-way ANOVA; F (2,8) = 17.42, p< 0.01; n = 3 per 
group) or BrdU and NeuN (Figure 1C, One-way ANOVA; F (2,8) = 8.12, p< 0.05; n = 3 
per group) over the total BrdU positive population. Furthermore, both treatments 
decreased the total newborn neuron population, identified by Dcx expression (Figure 
1D, One-way ANOVA; F (2,14) = 13.27, p= 0.01; n = 3-6 per group). Thus, we conclude 
that LPS either administered prenatally or during adulthood decreases adult 
neurogenesis to the same extent. 
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To rule out any effect of the adult saline injection, animals prenatally treated with LPS 
(LPS-only) or saline (saline-only) were analyzed without further manipulation in the 
adulthood. The ratio of adult newborn neurons (% BrdU-PSA-NCAM/total BrdU cells) 
observed in the prenatal LPS and saline groups without further manipulation was similar 
to the LPS/Saline7 or Saline/Saline7 groups, respectively (prenatal saline-only: 71.60 ± 
2.22; n=5, prenatal LPS-only: 50.47 ± 4.04; n=6; Student’s t test t (9) = 4.31, p< 0.01). 
These results observed in the prenatal-only treatments discard any effect of the 
injection of saline solution in the adult and are in agreement with previous results using 
the same experimental model but other cell markers (Graciarena et al, 2010). 
Based on these results, we wondered whether the detrimental effects of adult LPS 
exposure on adult neurogenesis in the DG had long-lasting effects, as observed for 
prenatal LPS treatment. To address this issue, adult animals (PD60) were injected with 
a comparable LPS regime than prenatally treated animals: adult animals received 4 
injections, every other day, of either saline (Saline60 group) or LPS (ip, 1 mg/kg; LPS60 
group). At PD120, 60 days after the last LPS injection (the same time period for the 
prenatally treated rats to reach adulthood), the animals received 7 daily injections of 
BrdU and later sacrificed and their brains analyzed (Figure 2A). The neuronal 
differentiation rate, represented as the percentage of double stained BrdU/NeuN cells 
over the BrdU positive population in the DG, was analyzed. The neuronal differentiation 
rate was equivalent 60 days after adult LPS or saline administration (Figure 2B, 
Student´s t-test t (6) = 1.3 p= 0.24, n = 4 per group). Moreover, total adult newborn 
neuron population, detected as cells positive for Dcx throughout the SGZ of the DG, 
was unchanged in LPS60 group relative to Saline60 group (Figure 2C, Student´s t-test t 
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(6) = 1.71, p= 0.14, n = 4 per group). These results indicate that adult LPS exposure no 
longer affects adult neurogenesis after 60 days of administration.  
Hence, these data show that long lasting effects of LPS treatment on adult 
neurogenesis occurs when it is administered prenatally, not in adulthood, suggesting 
that this gestational period is a critical window for programming of adult neurogenesis in 
the DG. 
Prenatal LPS treatment decreases adult neurogenesis specifically in the DG but 
not in the SVZ or the migrating neuroblasts in the RMS. 
We next examined the regional specificity of the prenatal LPS effect and analyzed the 
SVZ, the other well-characterized adult neurogenic zone and the RMS, the region 
where neuroblasts migrate to the olfactory bulb. We quantified the percentage of cells 
positive for BrdU and Dcx over the total BrdU-positive population in adult rats treated as 
previously described. Neither prenatal LPS (LPS/Saline7) nor adult LPS (Saline/LPS7) 
treatment affected adult neurogenesis in the SVZ (Figure 3A:One-way ANOVA; F (2,8) 
= 0.11, p = 0.89; n = 3 per group) or the population of cells undergoing proliferation 
(BrdU-positive/mm3) (Figure 3D: One-way ANOVA; F (2,8) = 0.35, p = 0.71; n = 3 per 
group). In order to study if the LPS treatment could affect the migrating neuroblasts 
along the RMS, the same quantitation was performed. No significant differences in the 
number of migrating neuroblasts (% of BrdU-Dcx/total BrdU cells) or cells undergoing 
proliferation (BrdU-positive/mm3) were observed among the groups studied (Figure 3B: 
One-way ANOVA; F (2,8) = 2.26, p = 0.18; n= 3 per group; Figure 3E: Total BrdU/mm3, 
One-way ANOVA; F (2,8) = 1.81, p = 0.24; n= 3 per group and Figures 3C, F and G). 
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Taken together these results show that prenatal LPS treatment decreases adult 
neurogenesis preferentially in the DG but not in the SVZ and does not influence the 
number of migrating neuroblasts in the RMS. 
Microglial but not astrocytic activation correlates with reduced adult 
neurogenesis regionally and temporally 
Next, we sought to determine the differences in the adult neurogenic niche that would 
explain the duration of the effects of prenatal vs. adult LPS. Microglia and astrocytes are 
main mediators of the LPS effects and important players in regulating NSC functions. 
Hence, we first wondered whether any of these cell types showed morphological 
alterations in response to LPS administration, along with the observed effects on adult 
neurogenesis. 
Microglia activation can be classified according to their morphology (Kreutzberg, 1996); 
see Methods). We aimed to compare the extent and duration of microglial activation 
upon prenatal or adult LPS exposure in the DG and the SVZ. We use the lectin GSAI-
B4 to detect microglial cells in all stages of activation in the tissue sections. Microglial 
cells of the DG were morphologically shifted to an activated state to the same extent in 
LPS/Saline7 and Saline/LPS7 groups compared to the Saline/Saline7 group (Figure 4A-
D, One-way ANOVA; F (2,12) = 21.97, p< 0.001; n = 4-5 per group). No significant 
differences were observed among the LPS treated groups, also all activated cells were 
at the activation stages II or III, but not IV (Figure 4 A to C). On the contrary, no 
significant microglial activation was observed in animals injected with LPS or saline in 
adulthood and analyzed 60 days later (Figure 4 E and F, n=4 per group). We also tested 
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the SVZ for microglial activation after prenatal LPS injection. No differences were 
observed in morphological changes among the different groups. (Supplementary Figure 
1 A and C, n=3/group). Finally, microglial activation was not seen in other brain regions 
such as cortex, thalamus, or hypothalamus, indicating that microglial activation in the 
DG is specific.         
We then searched for any evidence of astrocytosis in the DG in prenatally or adult LPS-
treated animals 7 days after treatment. We evaluated astrocyte morphology as well as 
GFAP-labeling intensity in the DG or SVZ of animals treated with LPS prenatally or 
during adulthood. No differences were observed among the Saline/Saline7, 
Saline/LPS7 or LPS/Saline7 experimental groups analyzed in the DG (Supplementary 
Figure 2A to C) or the SVZ (Supplementary Figure 1B and D). Thus, neither prenatal 
nor adult LPS exert any effect on astrocytes in the DG or the SVZ of adult animals at 
the time points tested. 
These results indicate that, microglial activation was observed only in the experimental 
groups were reduced neurogenesis was detected (prenatal and adult LPS after 7 days) 
and specifically in the brain region with reduced neurogenesis (DG) and not in another 
neurogenic region (SVZ). Importantly, long-lasting effects of LPS on microglial activation 
were also in accordance with the effects on adult neurogenesis, i.e. only the animals 
treated prenatally with LPS showed activated microglial cells in the DG 60 days after 
treatment. Astroglia did not present morphological alterations in response to prenatal or 
adult LPS treatment either in the DG or the SVZ, showing that microglial cells are the 
preferential cellular targets of LPS in the DG in our experimental paradigm. 
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Prenatal and adult LPS administration causes differential alterations in TGF-β1 
mRNA levels in the adult 
In order to analyze the molecular alterations in the neurogenic niche that could underlie 
the reduction observed in adult neurogenesis, we analyzed the expression of 
transforming growth factor β1 (TGF-β1) and Interleukin-6 (IL-6) in the adult 
hippocampus. TGF- β1 is an anti-inflammatory cytokine which has been shown to be a 
key mediator of the reduced neurogenesis caused by prenatal LPS administration 
(Graciarena et al, 2010; Mathieu et al, 2010a) and IL-6 is a pro-inflammatory cytokine 
involved in adult LPS-mediated reduction in adult neurogenesis (Monje et al, 2003; 
Vallieres et al, 2002). 
Therefore, we aimed to compare TGF-β1 mRNA levels in the hippocampi of adult 
animals that received LPS either prenatally or 7 days earlier in adulthood by real time 
RT-PCR. As shown in Figure 5A, when compared with the Saline/Saline7 group, the 
LPS/Saline7 group showed lower TGF-β1 mRNA levels in the hippocampus, while the 
Saline/LPS7 group did not show altered TGF-β1 mRNA levels after 7 days (Figure 5A, 
One-way ANOVA; F (2,20) = 3.74, p= 0.04; n = 6-8 per group). Moreover, TGF-β1 
mRNA levles did not change 60 days after adult saline or LPS treatment (Saline60: 7.18 
± 1.07; LPS60: 8.02 ± 0.64, Student´s t test t (6) = 0.67, p = 0.53; n=4/group).  
Neither prenatal nor adult LPS treatment caused any alterations in IL-6 mRNA  levels in 
the hippocampus (Figure 5B, One-way ANOVA; F (2,15) = 0.16, p = 0.85; n = 4-7 per 
group). These results indicate that the immune molecular component of the neurogenic 
niche is differentially affected by LPS administration at the prenatal or adult period: 
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prenatally administered LPS did cause a lower TGF-β1 mRNA levels in the 
hippocampus of the adult offspring, while LPS administered in adulthood did not, 
independently from the time of analysis. Interestingly, the diminution of TGF-β1 mRNA 
levels correlates with the only treatment where the LPS effects on neurogenesis are 
long-lasting (prenatal LPS).  
The pro-neurogenic effect of TGF-β1 is exerted through its canonical Smad 
pathway. 
TGF-β1 signals through different pathways, Smad2/3 being the most frequent and the 
canonic one (Derynck & Zhang, 2003, Massague & Gomis, 2006). We next examined 
the possibility that TGF-β1 could be exerting its pro-neurogenic properties via the Smad 
signal transduction pathway. To this aim, we first attempted to study p-Smad 2/3 
expression in whole hippocampi but the Western Blot was not sensitive enough to 
detect p-Smad 2/3 in any sample tested, most likely due to the dilution of the signal with 
other cell types in the sample. Therefore, NSC cultures were used to test the 
involvement of the Smad pathway on the pro-neurogenic effects of TGF- β1. NSC were  
prepared from the adult DG and transduced with a replication-deficient adenovector 
expressing Smad7 (AdSmad7), an endogenous inhibitor of the Smad2/3 pathway (Zhu 
& Burgess, 2001), or β-galactosidase (Adβgal), as control. TGF-β1 (0.1 or 1 ng/ml) was 
added to NSCs media 24hs after the adenovector transduction.  
First, we tested whether the Smad2/3 pathway was functional on these cells, and 
whether the pre-incubation with AdSmad7 prevented Smad2/3 pathway activation upon 
TGF-β1 incubation. We performed Western blot analyses for Smad7, phosphorylated 
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Smad2/3 (p-Smad2/3), and actin as a load control (Figure 6A), at 30 min after TGF-β1 
addition to the media. Smad7 expression was evident from 24 hs (Figure 6A, upper 
panel) to 5 days after NSC transduction with AdSmad7 (data not shown), confirming the 
expression of the Smad7 protein by the adenoviral vector. The quantitation of the p-
Smad2/3 and actin bands by optic densitometry showed that 1ng/ml TGF-β1 provoked 
an increase in p-Smad2/3, while pre-incubation of NSCs with AdSmad7 partially 
prevented this increase (Figure 6A and B, Two way ANOVA. Adenoviral treatment: F 
(1,12) = 28.47, p< 0.001; TGF-β1 treatment: F (2,12) = 53.51, p<0.001; Interaction: F 
(2,12) = 4.06, p= 0.045; n = 3 per group). Thus, we can conclude that the Smad2/3 
pathway is activated by TGF-β1 in NSCs, and that pre-incubation of NSCs with 
AdSmad7 prevents Smad2/3 pathway activation upon this treatment. 
Next, we tested the functional effects of the activity of the Smad2/3 pathway in NSC 
neuronal differentiation. To this aim, NSCs were incubated with 1 ng/ml TGF-β1 for 4 
days, and then fixed for immunocytochemistry against β-III-tubulin, a marker of neuronal 
lineage (Figure 6C to 6F). The percentage of β-III-tubulin positive cells/total number of 
cells was quantified (Figure 6G). As expected, TGF-β1 increased the percentage of β-
III-tubulin-positive cells in the preparation with no adenovector transduction as well as in 
cells previously transduced with Adβgal. On the contrary, pre-incubation of NSCs with 
AdSmad7 prevented the increase in the neuronal population upon TGF-β1 incubation 
(Figure 6G, Two way ANOVA. Adenoviral treatment: F (1,10) = 7.71, p< 0.05; TGF-β1 
treatment: F (2,10) = 10.81, p< 0.01; Interaction: F (2,10) = 10.96, p< 0.01; n = 2-3 per 
group). Based on these results, we can conclude that TGF-β1 exerts its pro-neurogenic 
effects on NSCs through the Smad2/3 signaling pathway. 
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DISCUSSION 
In this study we aimed to investigate the regional and temporal specificity of the effects 
of peripheral inflammation on adult neurogenesis. 
First, we found that both prenatal and adult LPS administration impair adult 
neurogenesis in the DG to the same extent. However, while prenatal LPS decreases 
adult neurogenesis in the adult offspring, and hence its effects are long lasting; adult 
LPS effects are acute and reversible, and no longer evidenced 60 days after treatment. 
The same dynamics of LPS effects on adult neurogenesis are also evidenced on 
microglial activation in the DG: prenatal LPS causes long term microglial activation in 
the DG of the adult offspring; while adult LPS causes acute microglial activation, 
evidenced after 7 days but no longer after 60 days. We show evidence of differential 
molecular mechanisms underlying LPS effects at prenatal or adult stages: while 
prenatal LPS involves TGF-β1 downregulation in the DG, LPS administered in 
adulthood does not cause any changes in TGF-β1 levels concomitant to the decrease in 
adult neurogenesis. The effects of prenatal LPS were specific for the DG: no effects on 
adult neurogenesis, cell proliferation or microglial activation were observed in the SVZ, 
the other well-characterized neurogenic region in the adult rodent brain (see Table 1) or 
the RMS. Finally, we further explored the intracellular pathway involved in TGF-β1 pro-
neurogenic effects and found that Smad2/3, the canonical TGF-β1 signaling pathway, is 
involved in its pro-neurogenic effects in vitro.  
Hence, the prenatal period represents a temporal window of vulnerability of the DG to 
LPS administration with long-term consequences in adult neurogenesis levels and 
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microglia activation, involving downregulation of TGF-β1 expression, which probably 
exerts its effects on NSCs via activating the Smad2/3 pathway. 
Other groups have previously reported that LPS administered in adulthood impairs 
neurogenesis acutely (Fujioka & Akema, 2010; Monje et al, 2003). However, no 
previous work has assessed the duration of those effects. We decided to evaluate adult 
neurogenesis 60 days after adult LPS treatment, since it is the same period after which 
animals treated prenatally with LPS were analyzed. We show that 60 days after LPS 
injection, no effects on neuronal differentiation or the total number of newborn neurons 
in the DG were observed. In addition, we have corroborated previous results on the 
effects of prenatal LPS exposure on adult neurogenesis in the DG (Graciarena et al, 
2010) using a different marker of neuronal lineage (PSA-NCAM). These results 
altogether indicate that whereas prenatal LPS effects on neurogenesis are persistent 
and long lasting, adult LPS effects are acute and transient (see Table 1). Interestingly, a 
previous report has shown that adult LPS had no effect on adult neuronal differentiation 
(Bastos et al, 2008). This discrepancy could be due to different experimental designs. In 
the work by Bastos and colleagues, the animals received only one BrdU injection 5 hrs 
after LPS injection, and were analyzed 7 days later. Therefore, the neuronal 
differentiation rate studied represents the immediate time point after LPS injection, 
rather than the period of 7 days between LPS treatment and analysis that we report 
here. These different results might be explained by hypothesizing that adult LPS may 
cause its effects on neuronal differentiation of NSCs with a certain delay (which may 
allow for microglial activation to occur), and hence, would not be reflected by the 
neuronal differentiation of NSC population stained with BrdU immediately (5 hrs) after 
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LPS stimulus. Curiously, in our work, the magnitude of adult neurogenesis reduction in 
the prenatal and adult LPS–treated animals was similar (see Figure 1). It is tempting to 
speculate that there is a specific NSC subpopulation that is affected by LPS irrespective 
of its time of inoculation and additional factors render the effect of LPS long-lasting or 
acute. One such factor could be the reduced levels of TGF-1 expression (as discussed 
below). 
We did not observe any differences in the GCL area at PND60 upon prenatal LPS 
treatment (data not shown), as it could be expected as a consequence of a chronic 
reduction in adult neurogenesis. Our data is in agreement with those of Lemaire and 
collaborators, where cumulative differences in total granule cell number owing to a 
lesser extent of adult neurogenesis could not be observed before 3 months of age in 
prenatally stressed rats (Lemaire et al., 2000). Thus, taking into account the relatively 
small proportion of adult-newborn granule neurons as compared to the 1-2 million 
neurons already present in the GCL, we favor the hypothesis that only a longer period 
of decreased adult neurogenesis (at least 3 months) than the one analyzed in this study 
will modify the total granule cell number. 
The same dynamics and regional specificity of LPS effects on adult neurogenesis were 
also evidenced on microglial activation: prenatal LPS causes long term microglial 
activation in the DG of the adult offspring, while adult LPS causes acute microglial 
activation, evidenced after 7 days but no longer after 60 days. In addition, the astrocyte 
population does not seem to play a major role in mediating the LPS effects since no 
significant differences in astrocyte activation were found among the prenatally or adult 
treated animals at any time point studied, either in the DG or the SVZ (see Table 1). 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
27 
 
Based on these results we can conclude that i) microglial but not astrocytic activation 
occurs concomitantly with adult neurogenesis decrease; and ii) long term microglial 
activation only occurs in the DG when LPS is administered prenatally. Hence, these 
observations favor the possibility that adult TGF-β levels were down-regulated in 
hippocampal microglial cells rather than in astrocytes. 
Several hypotheses could be envisaged to explain the specificity of the effects of pre-
natal LPS on adult neurogenesis and microglial activation in the DG but not in the SVZ. 
First, the hippocampal region has been previously shown to respond differentially to 
prenatal inflammation compared to other brain regions (Fatemi et al, 2008, Golan et al, 
2009). For example, Golan and co-workers have shown that LPS injected at GD17 
affects the hippocampus but not the cerebral cortex or cerebellum, which correlates with 
impaired forms of learning and memory but no alteration in motor function in the adult 
offspring. In addition, the adult offspring of influenza virus-infected pregnant mice at 
GD18 showed specific different gene expression patterns in the cortex, hippocampus or 
cerebellum, suggesting a specific regional response to inflammation. In addition, the 
timing and characteristics of neuronal development in both regions are not similar 
(Kriegstein & Alvarez-Buylla, 2009). The generation of hippocampal neurons in the fetal 
brain starts around the time of the first LPS injection in our model (GD14) (Angevine, 
1965). Interestingly, microglial cells start to enter the brain parenchyma around a similar 
time period (Dalmau et al, 1997). On the other hand, the embryonic SVZ play a major 
role in the generation of neurons in the whole brain from the beginning of 
neuronegenesis (Kriegstein & Alvarez-Buylla, 2009). Therefore, there could be different 
windows of susceptibility to inflammation for the developing DG and SVZ. The 
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experimental exploration of this issue, albeit of importance, is beyond the scope of this 
work.  
At the molecular level, we observed that TGF-β1 expression in the adult hippocampus is 
downregulated when LPS is administered prenatally (LPS/Saline7) but not when 
injected in adulthood (Saline/LPS7). On the other hand, IL-6 expression, which has 
been proposed as a microglial produced cytokine upon adult LPS exposure with an anti-
neurogenic role (Monje et al, 2003), was not affected by prenatal or adult LPS affected 
in our experimental paradigm (see Table 1). Thus, we conclude that the effects of LPS 
on adult neurogenesis involve differential molecular mechanisms whether it is 
administered prenatally or in the adulthood. It is interesting to note that the 
downregulation of TGF-β1 expression is the only variable tested that correlates with the 
long-term effects of prenatal LPS on adult neurogenesis and microglial activation and is 
not changed in the adult LPS paradigm irrespective of the time points studied. These 
observations add proof to previous observations demonstrating a functional role of TGF-
β1 downregulation in mediating long-term effects of LPS (Graciarena et al, 2010). In 
conclusion, the mechanisms by which pre-natal and adult LPS diminish adult 
neurogenesis are different and our data suggest that TGF-β expression levels play a 
major role in the final outcome of these treatments. Previously, we have observed TGF- 
β, IL-1β and IL-6  induction in the brain of pups whose dams have been treated with the 
same dose of LPS as in this study (Graciarena et al, 2010), indicating a typical 
response to LPS.  However, we cannot rule out that the dams play an important role in 
conveying different LPS-derived signals to the pups than the one that is received 
directly by LPS administration in the adult brain. In turn, these additional signals could 
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be responsible for the chronic downregulation of TGF-β in the hippocampus of 
prenatally-treated animals compared with the unaltered TGF-β levels after LPS 
treatment in the adults.      
Finally, we aimed to characterize the pro-neurogenic effects of TGF-β1. We have 
previously shown that TGF-β1 increases neuronal differentiation of adult NSC in vitro 
(Battista et al, 2006). Here, we studied whether the canonic signaling pathway triggered 
by TGF-β1 was involved in this effect. We showed that Smad2/3, TGF-β1 main 
signaling pathway, mediates its pro-neurogenic effects on a NSCs culture. Smad2/3 has 
been shown to be a transcriptional modulator of several target genes whose functions 
include cell cycle modulation and cell differentiation  (Chang et al, 2002, Moustakas et 
al, 2001, Shi & Massague, 2003). The actual molecular targets of Smad2/3 deserved 
further investigation to pinpoint the molecules responsible for the pro-neurogenic effect 
of TGF-β1 in vitro. In addition, whether the LPS effects on NSCs are cell autonomous or 
not could be explored by analyzing NSC derived from LPS-treated animals.  
Overall, our results contribute to highlighting the differential vulnerability of the prenatal 
CNS, as opposed to the adult CNS, to suffer long-term functional alterations due to pro-
inflammatory insults, and thus supporting the relevance of the programming concept 
occurring during the prenatal period but not in adulthood. In addition, it provides regional 
and temporal specificity for the anti-neurogenic effect of inflammation triggered by LPS. 
Importantly, the effects of prenatal LPS may reflect a non-overt concern on adult 
neurogenesis. As stated in the Introduction, approximately 14% of pregnant women get 
bacterial vaginosis, a condition during pregnancy that put the developing fetus into 
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contact with LPS (Dammann & Leviton, 1997, Purwar et al, 2001, Romero et al, 1989, 
Thorsen et al, 1998, Yoon et al, 1997). It is then tempting to speculate that fetal 
exposure to inflammation could affect the developing CNS, specifically reflecting in a 
lower adult neurogenesis in the DG. In this context, future studies that consider the 
differential vulnerability of the developing DG upon inflammatory stimuli, will be helpful 
to reach a better understanding of this relation and for early prevention of diverse adult 
hippocampal dysfunctions. 
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Table 1 
 Adult 
neurogenesis 
Microglial 
activation 
Astrocyte 
activation 
TGF-b1 
mRNA 
levels 
IL-6 mRNA 
levels 
Prenatal 
LPS 
(DG) 
Reduced  Increased (types 
II and III) 
Unaltered Reduced Unaltered 
Prenatal 
LPS 
(SVZ) 
Unaltered  Unaltered Unaltered ND ND 
Prenatal 
LPS 
(RMS) 
Unaltered 
(migrating 
neuroblasts)  
ND ND ND ND 
Adult 
LPS (7 
days 
analysis) 
(DG) 
Reduced Increased (types 
II and III) 
Unaltered Unaltered Unaltered 
Adult 
LPS (7 
days 
Unaltered Unaltered ND ND ND 
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analysis) 
(SVZ) 
Adult 
LPS (60 
days 
analysis) 
Unaltered  Unaltered Unaltered ND ND 
Table 1: Summary of the results obtained using the different inflammatory 
paradigms and times and regions of analysis. ND= not determined  
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FIGURE LEGENDS 
Figure 1. Prenatal or adult LPS exposure after 7 days impairs adult neurogenesis 
to the same extent. A. Timeline of the experimental approach. B, C, E, F, H and I: 
Immunohistochemistry and quantitation of newborn neurons. D. Percentage of double-
labeled BrdU-PSA-NCAM cells over total BrdU positive cells in the SGZ of the DG. G. 
Percentage of double-labeled BrdU-NeuN cells over total BrdU positive cells in the SGZ 
of the DG. J. Total number of Dcx-positive cells in the SGZ per mm3 of DG. Left column 
shows representative confocal/fluorescent images. GCL: Granular cell layer, H: Hilus. 
Scale bar: 50 µm. Values are the mean ± SEM. Tukey’s post-hoc test *p<0.05, **p<0.01 
vs. Saline/Saline7 group. 
Figure 2. Adult LPS does not impair adult neurogenesis after 60 days. A. Timeline 
of the experimental approach. B. Percentage of double-labeled BrdU-NeuN over total 
BrdU positive cells in the DG. C. Total number of Dcx-positive cells in the SGZ per mm3 
DG.. Values are the mean ± SEM. 
Figure 3. SVZ neurogenesis and neuroblast migration in the RMS are not affected 
by the prenatal LPS treatment. Immunohistochemistry and quantitation of newborn 
neurons. A-B. Percentage of cells labeled with Dcx among the BrdU-positive population 
in the SVZ (A) and RMS (B). Values are the mean ± SEM Tukey’s post-hoc test, no 
statistical significance. C. Representative confocal image of cells quantified in B. D-E. 
Quantitation of the total number of BrdU-positive cells in the SVZ (D) and RMS (E) per 
mm3. Values are the mean ± SEM. Tukey’s post-hoc test, no statistical significance. F. 
Representative diagram of a sagittal section of the rat brain showing the SVZ, RMS and 
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OB. The migration of the neuroblasts from the SVZ towards the OB is represented with 
a red line. The analyzed area is the one between the two vertical lines. G.  Composite 
image of the analyzed area in the SVZ and RMS. Scale bars: C, 50 µm; G, 100 m 
SVZ, Subventricular zone; RMS, rostral migratory stream; LV, lateral ventricule; OB, 
olfactory bulb. 
Figure 4. Prenatal LPS causes long term microglial activation, while adult LPS 
provokes transient microglial activation. A-C. Histochemistry analysis using GSAI-
B4 showing microglial activation in the DG in: Saline/Saline7 (A), LPS/Saline7 (B), and 
Saline/LPS7 (C) groups. Inset in A shows a larger image of a typical microglial cell 
activated to Stage I. Insets in B and C show a larger image of typical microglial cells 
activated to Stages  II-III. D. Quantitation of activated microglial cells (Stages II-III) per 
mm3 DG. E-F. Histochemistry analysis using GSAI-B4 showing microglial activation in 
the DG in the Saline60 group (E), and the LPS60 group (F). Scale bar: 50 µm. Values 
are the mean ± SEM. Tukey´s post-hoc test, **p<0.01, ***p<0.001 vs. Saline/Saline7 
group. 
Figure 5. Prenatal and LPS exposures cause differential alterations in local 
inflammatory cytokine expression. Analysis by real time RT-PCR of the mRNA levels 
in the hippocampal tissue of adult rats from Saline/Saline7, LPS/Saline7, and LPS/LPS7 
groups. A. TGF-β1. B. IL-6. Values are the mean  SEM. Tukey’s post-hoc test, 
*p<0.05 vs. Saline/Saline7 group. β2m: β2-microglobulin. 
Figure 6. TGF-β1 exerts its pro-neurogenic effects on NSCs via its canonic 
pathway, Smad 2/3. A-B. Protein expression analysis of NSCs transduced with 
AdSmad7 or Adβgal recombinant adenovectors, 30 min after TGF-β1 or mock 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
35 
 
treatment. A. Representative Western blot of Smad7, phosphorylated (p-) Smad 2/3 and 
actin. B. OD quantitation of the p-Smad2/3 relative to actin bands, corresponding to 3 
independent experiments. Values are the mean  SEM. Tukey’s post-hoc test, **p<0.01; 
***p<0.001. C-G. Immunocytochemistry and cell quantitation of NSCs transduced with 
AdSmad7 or Adβgal recombinant adenovectors, 5 days after TGF-β1 or mock 
treatment. c. Control medium (No Ad) D. Control medium (No Ad) + TGF-β1 E. 
AdSmad7 + TGF-β1 F. Adβgal + TGF-β1 G. Quantitation of the percentage of β-III-
tubulin, averaged from 3 independent experiments, Violet: cell nuclei stained with 
Hoescht; pink: β-III-tubulin-positive cells. Values are the mean  SEM. Tukey’s post-hoc 
test, *p<0.05; ***p<0.001. Scale bar: 50 m.   
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Table 1 
 Adult 
neurogenesis 
Microglial 
activation 
Astrocyte 
activation 
TGF-b1 
mRNA 
levels 
IL-6 mRNA 
levels 
Prenatal 
LPS 
(DG) 
Reduced  Increased (types 
II and III) 
Unaltered Reduced Unaltered 
Prenatal 
LPS 
(SVZ) 
Unaltered  Unaltered Unaltered ND ND 
Prenatal 
LPS 
(RMS) 
Unaltered 
(migrating 
neuroblasts)  
ND ND ND ND 
Adult 
LPS (7 
days 
analysis) 
(DG) 
Reduced Increased (types 
II and III) 
Unaltered Unaltered Unaltered 
Adult 
LPS (7 
days 
analysis) 
Unaltered Unaltered ND ND ND 
  
(SVZ) 
Adult 
LPS (60 
days 
analysis) 
Unaltered  Unaltered Unaltered ND ND 
Table 1: Summary of the results obtained using the different inflammatory 
paradigms and times and regions of analysis. ND= not determined 
  
  
  
  
  
  
